Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation

BACKGROUND/AIMS: Tumor recurrence after curative therapy is common for patients with hepatocellular carcinoma (HCC). As fibrosis and chronic inflammation contribute to the progression of HCC, we aimed to identify the predictive value of inflammatory and fibrosis markers for HCC recurrence after cura...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hyun Ah, Kim, Jeong-Han, Hwang, Young, Choi, Hong Seok, Ko, Soon Young, Choe, Won Hyeok, Kwon, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763530/
https://www.ncbi.nlm.nih.gov/pubmed/26831608
http://dx.doi.org/10.4103/1319-3767.173760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763530/
https://www.ncbi.nlm.nih.gov/pubmed/26831608
http://dx.doi.org/10.4103/1319-3767.173760

Ejemplares similares